Go to Pathways list
Support our work
DONATE NOW

6th ESO-ESMO Latin American Masterclass in Clinical Oncology

Programme
MCO Coordinator: N. Pavlidis, GR
ESO Chair:
F. A. Peccatori, IT
ESMO Chair:
S. Peters, CH
Host Chair:
M. Chacon, AR
Scientific Advisors:
F. Cardoso, PT - A. Cervantes, ES - F. Lordick DE - R. Stahel, CH

The 6th ESO-ESMO Latin American Masterclass in Clinical Oncology is a closed event for selected participants.
Applications for this edition are closed. Applications for the 2022 edition will open soon.

Aims, objectives and teaching format
The Masterclass is a full immersion, clinical oriented event designed for medical and clinical oncologists focusing on multidisciplinarity. The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training.
It offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines. Participants will deliver case presentations within tumour boards and discuss them with an international faculty of top experts of each tumour type.
 
The Masterclass will be entirely in English and fluency in English is necessary for admission.

IMPORTANT INFORMATION
The Online Masterclass will be carried out in two different parts:
 
Part 1
Pre-recorded sessions will be made available from 24th March 2021 via this website, and will remain available for 1 month. You will be able to see all the sessions in your own time.
The pre-recorded sessions must be viewed before the Part 2 (Live weekend). 
When you finish watching a block on a specific tumour, please click on the link in each session and send us up to 3 questions related to the session. Some of your questions will be selected and answered during part 2 in the Q&A sessions. 
 
Part 2
Live sessions will be held on Saturday 24th and Sunday 25th April 2021.
During the live session, a lecture will be delivered for each main tumour group and will cover topics of interest for oncologists working in Arab and Southern European Countries. Each lecture will be followed by a Q&A session using some of the questions that were sent in part 1.
After the Q&A session, participants will present their clinical cases, which will be discussed by the experts.
 
Accreditation
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email. 
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 27 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
Application for CME recognition has been submitted to the European Society for Medical Oncology (ESMO) for ESMO-MORA accreditation, and 25 ESMO MORA cat. 1 credits have been granted to this event.
 
ESCO - The ESO College

Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. 
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.
 
Social media
Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology
 
Should you have any queries, please do not hesitate to contact the event organisers:
Laura Richetti - Organisation - lrichetti@eso.net
Alice Ciocchini - Organisation - aciocchini@eso.net
Mariachiara Deleo - e-ESO Assistant - mdeleo@eso.net
Francesca Marangoni - e-ESO Executive Manager -  fmarangoni@eso.net
 
The Masterclass in Clinical Oncology is an ESO-ESMO joint event 

 

In collaboration with

     

Under the auspices of
        

 
Communication skills workshop held in collaboration with  

The event will remain available until April 2022.
 

Programme

Expert: Nicholas Pavlidis

Expert: Solange Peters

Neoadjuvant and adjuvant therapy in triple negative breast cancer: past present and near future

Expert: Sandra Ximena Franco Millan

Q&A session

Expert: Santiago Bella

Expert: Fatima Cardoso

Expert: Sandra Ximena Franco Millan

Expert: Olivia Pagani

Expert: Santiago Bella

Expert: Olivia Pagani

Expert: Sandra Ximena Franco Millan

Expert: Fatima Cardoso

Antipodes in the treatment of rectal cancer

Expert: Juan Manuel O'Connor

Q&A session

Expert: Juan Manuel O'Connor

Expert: Javier Castillo

Expert: Andrés Cervantes Ruiperez

Expert: Florian Lordick

Expert: Javier Castillo

Expert: Andrés Cervantes Ruiperez

Expert: Juan Manuel O'Connor

Expert: Florian Lordick

Treatment of metastatic castration sensitive prostate cancer

Expert: Juan Pablo Sade

Q&A session

Expert: Juan Pablo Sade

Expert: Nicolas Mottet

Beyond high quality surgery plus chemotherapy to cure ovarian cancer patients

Expert: Gonzalo H. Giornelli

Q&A session

Expert: Gonzalo H. Giornelli

Expert: Cristiana Sessa

Expert: Juan Pablo Sade

Expert: Nicolas Mottet

Expert: Gonzalo H. Giornelli

Expert: Cristiana Sessa

Are mutated lung cancer suitable to avoid chemotherapy?

Expert: Claudio Martin

Q&A session

Expert: Claudio Martin

Expert: Carmen Pupareli

Expert: Solange Peters

Expert: Rolf A. Stahel

Expert: Carmen Pupareli

Expert: Rolf A. Stahel

Expert: Claudio Martin

Expert: Solange Peters

Expert: Nicholas Pavlidis

Expert: Solange Peters

Top